Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznaniem raka piersi (badanie mikroskopowe)
- •Przerzuty nowotworu do odległych organów
- •Planuje się lub już odbywająca się radioterapia (IMRT, SBRT lub terapia protonowa)
- •Chęć i możliwość uczestniczenia w badaniu zgodnie z jego wytycznymi
✗ Disqualifies
- •Brak możliwości lub chęci do uczestniczenia w badaniu zgodnie z jego wytycznymi
Simplified criteria — AI translation
Trial details
- Minimum age
- 19 Years
- Maximum age
- 100 Years
- Last updated (source)
- June 29, 2025
- Sex
- Female only
Locations (1)
Samsung Medical Center
Seoul, South Korea
Trial contact
Haeyoung Kim
won kyung Cho
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.